Synthesis and cytotoxic activity of certain trisubstituted azetidin-2-one derivatives as a cis-restricted combretastatin A-4 analogues
Date
2017
Journal Title
Journal ISSN
Volume Title
Type
Article
Publisher
Pharmaceutical Society of Korea
Series Info
Archives of Pharmacal Research
40
40
Scientific Journal Rankings
Abstract
Novel series of 1,3,4-trisubstituted azetidin-2-one derivatives 8a�p were synthesized and proposed as cytotoxic agents acting via inhibition of tubulin at the colchicine binding site. The design of the target compounds was based upon modification in the structure of the vascular targeting agent combretastatin A-4 (CA-4). The cis double bond linker in CA-4 was replaced with the azetidin-2-one ring aiming to prevent the cis/trans isomerization that suppresses the activity of CA-4, thereby enhancing its antiproliferative activity. All new compounds were investigated in vitro against MCF-7 and HCT-116 cell lines. The inhibition of tubulin polymerization by four most potent compounds 8g, 8j, 8n and 8o was also evaluated. The synthesis of the final targets was achieved adopting Staudinger reaction. Molecular modeling studies were performed to rationalize the biological results. � 2016, The Pharmaceutical Society of Korea.
Description
Scopus
Keywords
October University for Modern Sciences and Arts, جامعة أكتوبر للعلوم الحديثة والآداب, University of Modern Sciences and Arts, MSA University, Azetidin-2-one, Combretastatin A4, Cytotoxic activity, Tubulin, 3 chloro 4 (4 chlorophenyl) 1 (4 methoxyphenyl) 3 methyl azetidin 2 one, 3 chloro 4 (furan 2 yl) 1 (4 methoxyphenyl)azetidin 2 one, 4 (2 bromophenyl) 1 (3,4,5 trimethoxyphenyl) 3 (2 thienyl)azetidin 2 one, 4 (2 bromophenyl) 1 (3,4,5 trimethoxyphenyl) 3 phenylazetidin 2 one, 4 (2 bromophenyl) 3 chloro 1 (3,4,5 trimethoxyphenyl) 3 methylazetidin 2 one, 4 (2 bromophenyl) 3 chloro 1 (3,4,5 trimethoxyphenyl)azetidin 2 one, 4 (2 bromophenyl) 3 chloro 1 (4 methoxyphenyl) 3 methylazetidin 2 one, 4 (2 bromophenyl) 3 chloro 1 (4 methoxyphenyl)azetidin 2 one, 4 (3 bromophenyl) 1 (3,4,5 trimethoxyphenyl) 3 (2 thienyl)azetidin 2 one, 4 (3,4,5 trimethoxyphenyl) 1 (4 methoxyphenyl) 3 (2 thienyl)azetidin 2 one, 4 (4 bromophenyl) 1 (3,4,5 trimethoxyphenyl) 3 (2 thienyl)azetidin 2 one, 4 (4 bromophenyl) 1 (3,4,5 trimethoxyphenyl) 3 phenylazetidin 2 one, 4 (4 bromophenyl) 3 chloro 1 (4 methoxyphenyl)azetidin 2 one, 4 (4 chlorophenyl) 1 (3,4,5 trimethoxyphenyl) 3 (2 thienyl)azetidin 2 one, 4 (4 chlorophenyl) 1 (3,4,5 trimethoxyphenyl) 3 phenylazetidin 2 one, 4 (4 chlorophenyl) 1 (4 methoxyphenyl) 3 (2 theinyl)azetidin 2 one, azetidin 2 one derivative, azetidine derivative, colchicine, combretastatin A4, cytotoxic agent, unclassified drug, azetidine, azetidine derivative, bibenzyl derivative, combretastatin, cytotoxin, antiproliferative activity, Article, cytotoxicity, drug binding site, drug design, drug structure, drug synthesis, HCT 116 cell line, human, human cell, in vitro study, isomerization, MCF-7 cell line, microtubule assembly, molecular model, Staudinger reaction, structure activity relation, cell survival, drug effects, physiology, synthesis, Azetidines, Bibenzyls, Cell Survival, Cytotoxins, HCT116 Cells, Humans, MCF-7 Cells